Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- priority_score
- Composite prioritisation = 0.30*biology + 0.30*reagent-gap + 0.20*druggability + 0.10*disease + 0.10*novelty. Sub-scores are assigned during LLM-assisted curation — a heuristic ranking, NOT an experimental measurement.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- 1 if in the EV-Map circulating-EV proteome (Rai 2025); 3,422 targets.
- has_known_aptamer
- 1 if aptamer evidence found in PubMed/Aptagen (1,472 targets).
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for this protein AND (aptamer OR SELEX).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
3,374 rows where has_cryoEM = 0 and tier = "Tier 1.5" sorted by priority_score descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total
| id | gene_symbol | protein_name | tier | priority_score ▲ | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | drug_count_approved | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q9Y2C5 | SLC17A4 | Probable small intestine urate exporter | Tier 1.5 | 0.878 | 0 | 83.69 | 0 | 0 | 0 | 0 | 0 | inflammatory bowel disease | 0.09896486250497885 | ||||
| Q9NX14 | NDUFB11 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial | Tier 1.5 | 0.86 | 0 | 77.56 | 0 | 0 | 0 | 0 | 1 | Microphthalmia with linear skin defects syndrome | 0.7364493324598024 | ||||
| P0DPK4 | NOTCH2NLC | Notch homolog 2 N-terminal-like protein C | Tier 1.5 | 0.805 | 0 | 80.81 | 0 | 0 | 0 | 0 | 0 | neuronal intranuclear inclusion disease | 0.4999829066911242 | ||||
| P15260 | IFNGR1 | Interferon gamma receptor 1 | Tier 1.5 | 0.804 | 5 | 66.0 | 0 | 0 | 1 | 2 | 33667716 | 1 | disseminated atypical mycobacterial infection | 0.5414012388034828 | |||
| Q9UBT7 | CTNNAL1 | Alpha-catulin | Tier 1.5 | 0.795 | 0 | 84.06 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.31316995706583495 | ||||
| Q14031 | COL4A6 | Collagen alpha-6(IV) chain | Tier 1.5 | 0.79 | 0 | 47.41 | 0 | 0 | 0 | 0 | 0 | Dupuytren Contracture | 0.5880367459451578 | ||||
| P36888 | FLT3 | Receptor-type tyrosine-protein kinase FLT3 | Tier 1.5 | 0.788 | 11 | 75.94 | 0 | 0 | 1 | 6 | 41733039, 34364920, 31434881, 30237882, 29299123, 22411871 | 1 | acute myeloid leukemia | 0.8313389209288576 | |||
| P37023 | ACVRL1 | Activin receptor type-1-like | Tier 1.5 | 0.779 | 7 | 82.0 | 0 | 0 | 0 | 0 | 0 | telangiectasia, hereditary hemorrhagic, type 2 | 0.7951167515831324 | ||||
| P01568 | IFNA21 | Interferon alpha-21 | Tier 1.5 | 0.777 | 0 | 85.0 | 0 | 0 | 0 | 0 | 0 | renal cell carcinoma | 0.3695798546847018 | ||||
| P48023 | FASLG | Tumor necrosis factor ligand superfamily member 6 | Tier 1.5 | 0.775 | 3 | 80.19 | 0 | 0 | 1 | 1 | 16581027 | 0 | autoimmune lymphoproliferative syndrome type 1 | 0.6984292519156657 | |||
| Q9BVX2 | TMEM106C | Transmembrane protein 106C | Tier 1.5 | 0.77 | 0 | 80.81 | 0 | 0 | 0 | 0 | 0 | prostate carcinoma | 0.21737104399686757 | ||||
| P29017 | CD1C | T-cell surface glycoprotein CD1c | Tier 1.5 | 0.77 | 10 | 88.56 | 0 | 0 | 0 | 0 | 0 | neoplasm | 0.1106047389635713 | ||||
| P02776 | PF4 | Platelet factor 4 | Tier 1.5 | 0.77 | 10 | 75.06 | 0 | 0 | 1 | 10 | 33859620, 32366845, 31967847, 23847186, 23673861, 34248840, 32022468 | 1 | systemic scleroderma | 0.11523541376593864 | |||
| P27037 | ACVR2A | Activin receptor type-2A | Tier 1.5 | 0.769 | 5 | 83.56 | 0 | 0 | 0 | 0 | 1 | hepatocellular carcinoma | 0.4908023126074436 | ||||
| O14958 | CASQ2 | Calsequestrin-2 | Tier 1.5 | 0.767 | 4 | 90.5 | 0 | 0 | 0 | 0 | 1 | catecholaminergic polymorphic ventricular tachycardia | 0.7718998507471558 | ||||
| Q9H3K6 | BOLA2 | BolA-like protein 2 | Tier 1.5 | 0.765 | 0 | 92.69 | 0 | 0 | 0 | 0 | 1 | hepatocellular carcinoma | 0.08093942543094014 | ||||
| A0A1B0GTW7 | CIROP | Ciliated left-right organizer metallopeptidase | Tier 1.5 | 0.764 | 0 | 73.44 | 0 | 0 | 0 | 0 | 0 | heterotaxy, visceral, 12, autosomal | 0.6929422132808513 | ||||
| Q9BZR8 | BCL2L14 | Apoptosis facilitator Bcl-2-like protein 14 | Tier 1.5 | 0.76 | 0 | 62.38 | 0 | 0 | 0 | 0 | 0 | hypothyroidism | 0.33117514363294837 | ||||
| Q9BWF2 | TRAIP | E3 ubiquitin-protein ligase TRAIP | Tier 1.5 | 0.76 | 1 | 74.94 | 0 | 0 | 0 | 0 | 0 | Seckel syndrome 9 | 0.683878095944948 | ||||
| O15370 | SOX12 | Transcription factor SOX-12 | Tier 1.5 | 0.76 | 0 | 63.0 | 0 | 0 | 0 | 0 | 0 | type 2 diabetes mellitus | 0.3277369133971199 | ||||
| A6NI61 | MYMK | Protein myomaker | Tier 1.5 | 0.758 | 0 | 90.44 | 0 | 0 | 0 | 0 | 0 | Carey-Fineman-Ziter syndrome | 0.7790386256350393 | ||||
| Q16585 | SGCB | Beta-sarcoglycan | Tier 1.5 | 0.75 | 0 | 76.44 | 0 | 0 | 0 | 0 | 0 | autosomal recessive limb-girdle muscular dystrophy type 2E | 0.8154766151472349 | ||||
| Q9GZU2 | PEG3 | Paternally-expressed gene 3 protein | Tier 1.5 | 0.75 | 1 | 44.53 | 0 | 0 | 1 | 1 | 16595502 | 0 | neurodegenerative disease | 0.34815912577489827 | |||
| P18075 | BMP7 | Bone morphogenetic protein 7 | Tier 1.5 | 0.749 | 4 | 76.19 | 0 | 0 | 1 | 1 | 30537181 | 0 | Inguinal hernia | 0.4420059023371716 | |||
| P56730 | PRSS12 | Neurotrypsin | Tier 1.5 | 0.746 | 0 | 77.31 | 0 | 0 | 0 | 0 | 0 | intellectual disability, autosomal recessive 1 | 0.6621935416695687 | ||||
| Q92956 | TNFRSF14 | Tumor necrosis factor receptor superfamily member 14 | Tier 1.5 | 0.745 | 8 | 79.94 | 0 | 0 | 0 | 0 | 1 | diffuse large B-cell lymphoma | 0.5983171413833771 | ||||
| Q8N6D2 | RNF182 | E3 ubiquitin-protein ligase RNF182 | Tier 1.5 | 0.74 | 0 | 70.25 | 0 | 0 | 0 | 0 | 0 | periapical tissue disease | 0.304701328693288 | ||||
| Q14246 | ADGRE1 | Adhesion G protein-coupled receptor E1 | Tier 1.5 | 0.74 | 0 | 76.69 | 0 | 0 | 0 | 0 | 0 | diabetic ketoacidosis | 0.20424823130055986 | ||||
| P16112 | ACAN | Aggrecan core protein | Tier 1.5 | 0.74 | 4 | 51.91 | 0 | 0 | 0 | 0 | 0 | Familial osteochondritis dissecans | 0.7558487616449627 | ||||
| Q00LT1 | PRCD | Photoreceptor disk component PRCD | Tier 1.5 | 0.737 | 0 | 63.97 | 0 | 0 | 0 | 0 | 0 | retinitis pigmentosa | 0.7650522818524582 | ||||
| P98196 | ATP11A | Phospholipid-transporting ATPase IH | Tier 1.5 | 0.735 | 0 | 82.94 | 0 | 0 | 0 | 0 | 1 | hearing loss, autosomal dominant 84 | 0.5506821963658654 | ||||
| Q9Y4U1 | MMACHC | Cyanocobalamin reductase / alkylcobalamin dealkylase | Tier 1.5 | 0.735 | 7 | 85.62 | 0 | 0 | 0 | 0 | 0 | Methylmalonic acidemia with homocystinuria, type cblC | 0.8478185420804271 | ||||
| P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Tier 1.5 | 0.735 | 0 | 77.38 | 0 | 0 | 0 | 0 | 1 | genetic developmental and epileptic encephalopathy | 0.7513374591580034 | ||||
| Q9ULX7 | CA14 | Carbonic anhydrase 14 | Tier 1.5 | 0.734 | 2 | 90.69 | 0 | 0 | 0 | 0 | 0 | epilepsy | 0.4397024990575866 | ||||
| Q99593 | TBX5 | T-box transcription factor TBX5 | Tier 1.5 | 0.733 | 4 | 62.66 | 0 | 0 | 0 | 0 | 0 | Holt-Oram syndrome | 0.827317913681364 | ||||
| P20702 | ITGAX | Integrin alpha-X | Tier 1.5 | 0.732 | 9 | 88.0 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.41708750879240836 | ||||
| P53539 | FOSB | Protein FosB | Tier 1.5 | 0.73 | 12 | 59.12 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.22246010664492422 | ||||
| P09603 | Tier 1.5 | 0.729 | 8 | 57.41 | 0 | 0 | 0 | 0 | 1 | type 2 diabetes mellitus | 0.39219340856589974 | ||||||
| Q9P2B2 | PTGFRN | Prostaglandin F2 receptor negative regulator | Tier 1.5 | 0.728 | 0 | 84.12 | 0 | 0 | 0 | 0 | 1 | type 2 diabetes mellitus | 0.48052208463481294 | ||||
| P22732 | SLC2A5 | Solute carrier family 2, facilitated glucose transporter member 5 | Tier 1.5 | 0.728 | 0 | 90.56 | 0 | 0 | 0 | 0 | 1 | Prolonged QT interval | 0.3326218692162316 | ||||
| O43914 | TYROBP | TYRO protein tyrosine kinase-binding protein | Tier 1.5 | 0.728 | 5 | 64.62 | 0 | 0 | 0 | 0 | 0 | Nasu-Hakola disease | 0.7323368313860329 | ||||
| Q9Y5C1 | ANGPTL3 | Angiopoietin-related protein 3 | Tier 1.5 | 0.727 | 1 | 79.62 | 0 | 0 | 1 | 1 | 23770039 | 0 | familial hypobetalipoproteinemia 2 | 0.6739043862507132 | |||
| Q92636 | NSMAF | Protein FAN | Tier 1.5 | 0.725 | 0 | 88.31 | 0 | 0 | 0 | 0 | 1 | placental retention | 0.36802220150078147 | ||||
| Q6MZM0 | HEPHL1 | Ferroxidase HEPHL1 | Tier 1.5 | 0.72 | 0 | 89.44 | 0 | 0 | 0 | 0 | 0 | pili torti-developmental delay-neurological abnormalities syndrome | 0.40268634456935765 | ||||
| Q15399 | TLR1 | Toll-like receptor 1 | Tier 1.5 | 0.72 | 6 | 87.19 | 0 | 0 | 0 | 0 | 0 | asthma | 0.5956884825296496 | ||||
| Q9NWH7 | SPATA6 | Spermatogenesis-associated protein 6 | Tier 1.5 | 0.72 | 0 | 65.19 | 0 | 0 | 0 | 0 | 0 | hypothyroidism | 0.4205896274474635 | ||||
| P25100 | ADRA1D | Alpha-1D adrenergic receptor | Tier 1.5 | 0.716 | 0 | 64.81 | 0 | 0 | 0 | 0 | 0 | hypertension | 0.6613200073424285 | ||||
| O60882 | Tier 1.5 | 0.713 | 1 | 83.31 | 0 | 0 | 0 | 0 | 0 | Hypomaturation amelogenesis imperfecta | 0.7281006394540224 | ||||||
| P79483 | HLA-DRB3 | HLA class II histocompatibility antigen, DR beta 3 chain | Tier 1.5 | 0.71 | 2 | 88.38 | 0 | 0 | 0 | 0 | 1 | ||||||
| P41221 | WNT5A | Protein Wnt-5a | Tier 1.5 | 0.71 | 0 | 87.69 | 0 | 0 | 1 | 4 | 40855286, 32693649, 22363130, 18673242 | 1 | Robinow syndrome | 0.7220360983378594 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS SELECT f.id, n.gene_symbol, n.protein_name, tg.tier, f.priority_score, f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM, f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive, f.drug_count_approved, f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids, f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score FROM v_target_full f LEFT JOIN target_names n ON n.target_id=f.id LEFT JOIN targets tg ON tg.id=f.id LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id;